IL-1β inhibits human osteoblast migration

Molecular Medicine

Volumn 19, Issue 1, 2013, Pages 36-42

  Hengartner, Nina Emily ^a   Fiedler, Jörg ^a   Ignatius, Anita ^a   Brenner, Rolf E ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLATELET DERIVED GROWTH FACTOR BB; SOMATOMEDIN C; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN A;

ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FRACTURE HEALING; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STROMA CELL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-1BETA; MESENCHYMAL STROMAL CELLS; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOBLASTS; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTORS, INTERLEUKIN-1 TYPE I; RECOMBINANT PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84877092346     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2012.00058     Document Type: Article

References (35)

1. McKibbin B. (1978) The biology of fracture healing in long bones. J. Bone Joint Surg. Br. 60-B: 150-62.
2. Ai-Aql ZS, Alagl AS, Graves DT, Gerstenfeld LC, Einhorn TA. (2008) Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J. Dent. Res. 87:107-18.
3. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA. (2003) Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J. Cell. Biochem. 88:873-84.
4. Claes L, Recknagel S, Ignatius A. (2012) Fracture healing under healthy and inflammatory conditions. Nat. Rev. Rheumatol. 8:133-43.
5. Lind M, et al. (1995) Chemotaxis of human osteoblasts. Effects of osteotropic growth factors. APMIS. 103:140-6.
6. Fiedler J, Etzel N, Brenner RE. (2004) To go or not to go: Migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J. Cell. Biochem. 93:990-8.
7. Sanchez-Fernandez MA, Gallois A, Riedl T, Jurdic P, Hoflack B. (2008) Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling. PLoS ONE. 3:e3537.
8. Tsukamoto T, Matsui T, Fukase M, Fujita T. (1991) Platelet-derived growth factor B chain homodimer enhances chemotaxis and DNA synthesis in normal osteoblast-like cells (MC3T3-E1). Biochem. Biophys. Res. Commun. 175:745-51.
9. Colciago A, et al. (2009) In vitro effects of PDGF isoforms (AA, BB, AB and CC) on migration and proliferation of SaOS-2 osteoblasts and on migration of human osteoblasts. Int. J. Biomed. Sci. 5:380-9.
10. Mehrotra M, Krane SM, Walters K, Pilbeam C. (2004) Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells. J. Cell. Biochem. 93:741-52.
11. Fiedler J, Brill C, Blum WF, Brenner RE. (2006) IGF-I and IGF-II stimulate directed cell migration of bone-marrow-derived human mesenchymal progenitor cells. Biochem. Biophys. Res. Commun. 345:1177-83.
12. Nakasaki M, et al. (2008) IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts. Bone. 43:869-79.
13. Mayr-Wohlfart U, et al. (2002) Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone. 30:472-7.
14. Fiedler J, Leucht F, Waltenberger J, Dehio C, Brenner RE. (2005) VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem. Biophys. Res. Commun. 334:561-8.
15. Schoengraf P, et al. (2012) Does complement play a role in bone development and regeneration? Immunobiology. 218:1-9.
16. Schett G. (2011) Effects of inflammatory and antiinflammatory cytokines on the bone. Eur. J. Clin. Invest. 41:1361-6.
17. Rauner M, Sipos W, Pietschmann P. (2007) Osteo - immunology. Int. Arch. Allergy Immunol. 143:31-48.
18. Schraufstatter IU, Discipio RG, Zhao M, Khaldoyanidi SK. (2009) C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation. J. Immunol. 182:3827-36.
19. Ignatius A, et al. (2011) The anaphylatoxin receptor C5aR is present during fracture healing in rats and mediates osteoblast migration in vitro. J. Trauma. 71:952-60.
20. Kon T, et al. (2001) Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J. Bone Miner Res. 16:1004-14.
21. Pacifici R, et al. (1987) Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc. Natl. Acad. Sci. U. S. A. 84:4616-20.
22. Pacifici R, et al. (1989) Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc. Natl. Acad. Sci. U. S. A. 86:2398-402.
23. Delima AJ, Karatzas S, Amar S, Graves DT. (2002) Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists. J. Infect. Dis. 186:511-6.
24. Polzer K, et al. (2010) Interleukin-1 is essential for systemic inflammatory bone loss. Ann. Rheum. Dis. 69:284-90.
25. Tokukoda Y, et al. (2001) Interleukin-1beta stimulates transendothelial mobilization of human peripheral blood mononuclear cells with a potential to differentiate into osteoclasts in the presence of osteoblasts. Endocr. J. 48:443-52.
26. Nakashima T, et al. (2000) Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem. Biophys. Res. Commun. 275:768-75.
27. O'Gradaigh D, Bord S, Ireland D, Compston JE. (2003) Osteoclastic bone resorption in rheumatoid arthritis and the acute-phase response. Rheumatology. (Oxford). 42:1429-30.
28. Morike M, et al. (1995) Expression of osteoblastic markers in cultured human bone and fracture callus cells. J. Mol. Med. (Berl.) 73:571-5.
29. Huang C, Jacobson K, Schaller MD. (2004) MAP kinases and cell migration. J. Cell Sci. 117:4619-28.
30. Gilardetti RS, et al. (1991) High-affinity binding of PDGF-AA and PDGF-BB to normal human osteoblastic cells and modulation by interleukin-1. Am. J. Physiol. 261:C980-5.
31. Tsukamoto T, et al. (1991) Interleukin-1 enhances the response of osteoblasts to platelet-derived growth factor through the alpha receptor-specific up-regulation. J. Biol. Chem. 266:10143-7.
32. O'Neill LA. (2000) The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE. 2000:re1.
33. Ponte AL, et al. (2007) The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells. 25:1737-45.
34. Schmidt-Bleek K, et al. (2012) Inflammatory phase of bone healing initiates the regenerative healing cascade. Cell Tissue Res. 347:567-73.
35. Warashina H, et al. (2003) Biological reaction to alumina, zirconia, titanium and polyethylene particles implanted onto murine calvaria. Biomaterials. 24:3655-61.